These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37798537)

  • 1. Application of NMR and Chemometric Analyses to Better Understand the Quality Attributes in pH and Thermally Degraded Monoclonal Antibodies.
    Beaumont VA; Liu L; Shi H; Rouse JC; Kim HY
    Pharm Res; 2023 Oct; 40(10):2457-2467. PubMed ID: 37798537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches.
    Li M; Beaumont VA; Akbar S; Duncan H; Creasy A; Wang W; Sackett K; Marzilli L; Rouse JC; Kim HY
    MAbs; 2024; 16(1):2292688. PubMed ID: 38117548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics.
    Brinson RG; Marino JP; Delaglio F; Arbogast LW; Evans RM; Kearsley A; Gingras G; Ghasriani H; Aubin Y; Pierens GK; Jia X; Mobli M; Grant HG; Keizer DW; Schweimer K; Ståhle J; Widmalm G; Zartler ER; Lawrence CW; Reardon PN; Cort JR; Xu P; Ni F; Yanaka S; Kato K; Parnham SR; Tsao D; Blomgren A; Rundlöf T; Trieloff N; Schmieder P; Ross A; Skidmore K; Chen K; Keire D; Freedberg DI; Suter-Stahel T; Wider G; Ilc G; Plavec J; Bradley SA; Baldisseri DM; Sforça ML; Zeri ACM; Wei JY; Szabo CM; Amezcua CA; Jordan JB; Wikström M
    MAbs; 2019 Jan; 11(1):94-105. PubMed ID: 30570405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR based quality evaluation of mAb therapeutics: A proof of concept higher order structure biosimilarity assessment of trastuzumab biosimilars.
    Joshi S; Khatri LR; Kumar A; Rathore AS
    J Pharm Biomed Anal; 2022 May; 214():114710. PubMed ID: 35290923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR spectroscopy as a characterization tool enabling biologics formulation development.
    Ma J; Pathirana C; Liu DQ; Miller SA
    J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best Practices in Utilization of 2D-NMR Spectral Data as the Input for Chemometric Analysis in Biopharmaceutical Applications.
    Brinson RG; Arbogast LW; Marino JP; Delaglio F
    J Chem Inf Model; 2020 Apr; 60(4):2339-2355. PubMed ID: 32249579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemometric Methods to Quantify 1D and 2D NMR Spectral Differences Among Similar Protein Therapeutics.
    Chen K; Park J; Li F; Patil SM; Keire DA
    AAPS PharmSciTech; 2018 Apr; 19(3):1011-1019. PubMed ID: 29110294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principal Component Analysis of 1D 1H Diffusion Edited NMR Spectra of Protein Therapeutics.
    Elliott KW; Delaglio F; Wikström M; Marino JP; Arbogast LW
    J Pharm Sci; 2021 Oct; 110(10):3385-3394. PubMed ID: 34166704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minor N-Glycan Mapping of Monoclonal Antibody Therapeutics Using Middle-Down NMR Spectroscopy.
    Zhuo Y; Keire DA; Chen K
    Mol Pharm; 2021 Jan; 18(1):441-450. PubMed ID: 33305950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the higher order structure of Humira®, Remicade®, Avastin®, Rituxan®, Herceptin®, and Enbrel® by 2D-NMR fingerprinting.
    Hodgson DJ; Ghasriani H; Aubin Y
    J Pharm Biomed Anal; 2019 Jan; 163():144-152. PubMed ID: 30296716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-State NMR Characterization of Lyophilized Formulations of Monoclonal Antibody Therapeutics.
    Perodeau J; Arbogast LW; Nieuwkoop AJ
    Mol Pharm; 2023 Mar; 20(3):1480-1489. PubMed ID: 36702622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of High Resolution NMR Methods to Probe the Impact of Chemical Modifications on Higher Order Structure of Monoclonal Antibodies in Relation to Antigen Binding.
    Majumder S; Saati A; Philip S; Liu LL; Stephens E; Rouse JC; Alphonse Ignatius A
    Pharm Res; 2019 Jul; 36(9):130. PubMed ID: 31264003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate Analysis of Two-Dimensional
    Arbogast LW; Delaglio F; Schiel JE; Marino JP
    Anal Chem; 2017 Nov; 89(21):11839-11845. PubMed ID: 28937210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemometric Outlier Classification of 2D-NMR Spectra to Enable Higher Order Structure Characterization of Protein Therapeutics.
    Sheen DA; Shen VK; Brinson RG; Arbogast LW; Marino JP; Delaglio F
    Chemometr Intell Lab Syst; 2020; 199():. PubMed ID: 34135539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimisation of the use of sliding window deconvolution for comprehensive characterisation of trastuzumab and adalimumab charge variants by native high resolution mass spectrometry.
    Millán-Martín S; Carillo S; Füssl F; Sutton J; Gazis P; Cook K; Scheffler K; Bones J
    Eur J Pharm Biopharm; 2021 Jan; 158():83-95. PubMed ID: 33212184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principal component analysis for automated classification of 2D spectra and interferograms of protein therapeutics: influence of noise, reconstruction details, and data preparation.
    Brinson RG; Elliott KW; Arbogast LW; Sheen DA; Giddens JP; Marino JP; Delaglio F
    J Biomol NMR; 2020 Nov; 74(10-11):643-656. PubMed ID: 32700053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring size and oligomeric-state distribution of therapeutic mAbs by NMR and DLS: Trastuzumab as a case study.
    Joshi S; Khatri LR; Kumar A; Rathore AS
    J Pharm Biomed Anal; 2021 Feb; 195():113841. PubMed ID: 33371967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparability of higher order structure in proteins: chemometric analysis of second-derivative amide I Fourier transform infrared spectra.
    Stockdale G; Murphy BM; D'Antonio J; Manning MC; Al-Azzam W
    J Pharm Sci; 2015 Jan; 104(1):25-33. PubMed ID: 25382804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of NMR spectra with chemometrics.
    Winning H; Larsen FH; Bro R; Engelsen SB
    J Magn Reson; 2008 Jan; 190(1):26-32. PubMed ID: 18029207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of NMR in High Ordered Structure Characterization of Monoclonal Antibodies.
    Tokunaga Y; Takeuchi K
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.